NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), the former nutraceuticals business of Ashland Inc. (NYSE: ASH).

纽约-（商业新闻短讯）-Turnspire Capital Partners LLC（“Turnspire”）今天宣布，一家附属公司已完成对Pharmachem Innovations，LLC（“Pharmachem”或“公司”）的收购，Pharmachem Innovations，LLC是Ashland Inc.（纽约证券交易所：ASH）的前营养保健业务。

Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem.

此外，Turnspire运营合伙人莫里斯·墨菲（MauriceMurphy）被任命为执行主席，杰夫·罗杰斯（JeffRogers）被任命为Pharmachem的临时首席执行官。

Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufacturing capabilities for the nutrition market, handling everything from formula design and ingredient sourcing to finished product manufacturing.

Pharmachem是专有营养成分和定制配方服务的领先供应商，为营养产品公司提供广泛的活性成分和配方助剂组合。该公司还为营养市场提供定制配方和合同制造能力，处理从配方设计和配料采购到成品制造的一切事务。

Pharmachem has approximately 500 employees located at four production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico..

Pharmachem在美国新泽西州、犹他州和墨西哥塔毛利帕斯的四个生产工厂拥有大约500名员工。。

Mr. Murphy is an accomplished executive who has successfully led numerous private equity-owned businesses, including several carve-outs. He was President and Chief Executive Officer of UPG Company LLC, a Turnspire portfolio company from 2016 through 2022, executing a dramatic strategic, commercial and operational transformation that resulted in outsized returns for Turnspire investors..

墨菲先生是一位有成就的高管，他成功领导了许多私人股本拥有的企业，包括几家创业公司。2016年至2022年，他担任Turnspire投资组合公司UPG Company LLC的总裁兼首席执行官，执行了戏剧性的战略、商业和运营转型，为Turnspire投资者带来了巨额回报。。

Mr. Rogers has deep domain expertise in nutraceuticals, with over 30 years of relevant executive, commercial and operational experience. He was President and Chief Operating Officer of Niacet Corporation from 2019 through 2023, significantly contributing to a very successful exit for its private equity sponsor.

罗杰斯先生在营养保健领域拥有深厚的专业知识，拥有30多年的相关执行、商业和运营经验。2019年至2023年，他担任Niacet公司总裁兼首席运营官，为其私募股权赞助商的成功退出做出了重大贡献。

He previously served in progressively senior roles at National Starch & Chemical, Ashland and Lonza..

他之前曾在National Starch&Chemical、Ashland和Lonza担任高级职务。。

Turnspire Managing Partner Ilya Koffman said, “We are excited to acquire Pharmachem and its highly compelling formulation and manufacturing capabilities, underpinned by a broad portfolio of proprietary ingredients. Led by Maurice and Jeff, and with the benefit of Turnspire’s extensive experience transforming corporate carve-outs into thriving standalone companies, Pharmachem is well positioned to capitalize on attractive growth opportunities in its markets.”.

Turnspire管理合伙人伊利亚·科夫曼（IlyaKoffman）表示：“我们很高兴收购Pharmachem及其极具吸引力的配方和制造能力，这些能力得到了广泛的专有成分组合的支持。在莫里斯（Maurice）和杰夫（Jeff）的带领下，凭借Turnspire将企业创业转化为蓬勃发展的独立公司的丰富经验，Pharmachem处于有利地位，可以利用其市场上有吸引力的增长机会。”。

Mr. Murphy added, “I am delighted to join Pharmachem and to once again partner with Turnspire, which has a fantastic track record of supporting management teams to create and grow best-in-class businesses. I look forward to working with Jeff and the talented employees to build on Pharmachem’s rich legacy as an innovator in the exciting and rapidly growing nutraceuticals space.”.

墨菲先生补充道：“我很高兴加入Pharmachem，并再次与Turnspire合作，Turnspire在支持管理团队创建和发展一流企业方面有着出色的业绩记录。我期待着与杰夫和有才能的员工合作，在令人兴奋和快速增长的营养保健领域，作为创新者，巩固Pharmachem丰富的遗产。”。

Winston & Strawn LLP acted as legal counsel and Piper Sandler & Co acted as financial advisor to Turnspire on the transaction.

Winston＆Strawn LLP担任法律顾问，Piper Sandler＆Co担任Turnspire交易的财务顾问。

About Turnspire Capital Partners

关于Turnspire Capital Partners

Turnspire Capital Partners invests in high-quality businesses that have reached strategic, financial or operational inflection points and stand to benefit from our hands-on, operationally focused approach. Turnspire’s investment philosophy is predicated on creating value through operational improvements rather than through financial leverage.

Turnspire Capital Partners投资于已达到战略、财务或运营拐点的高质量业务，并将受益于我们以实际操作为重点的方法。Turnspire的投资理念是通过运营改进而不是通过财务杠杆创造价值。

Turnspire strives to make each of its portfolio companies best-in-class in their respective industry niche, and then to grow the businesses through organic initiatives or strategic acquisitions. For additional information, please visit www.turnspirecap.com..

Turnspire致力于使其投资组合中的每一家公司在各自的行业利基中成为一流的公司，然后通过有机举措或战略收购来发展业务。有关更多信息，请访问www.turnspirecap.com。。